For Minimally Invasive delivery devices that are high cost or difficult to manufacture, Creganna-Tactx Medical can conduct an in-depth value engineering examination.
Research indicates that supply-chain improvements can yield cost reductions up to 22%, process improvements & minor design changes can realize up to 46% reductions while product redesign can yield the greatest gains at 75-80%.
Our studies are conducted by a multi-disciplinary team of design, manufacturing & quality engineers and supply chain professionals. A detailed and objective study examines the product from a design & manufacturing perspective to identify potential cost savings and efficiency gains. Studies are typically conducted in a 4-6 week timeframe for a standard Minimally Invasive delivery device. Practical and effective solutions are advised at the conclusion of the study and, where appropriate, Creganna-Tactx Medical can work with you to implement these solutions across our global network.
- A fast-growing medical technology company wanted to create a robust and scalable manufacturing process for a newly approved delivery device utilized in EP applications. Subsequent to a detailed value engineering examination, product costs were reduced by 37% providing an 18 month ROI for the customer.
- A world leading medical devices company was pursuing a cost reduction strategy for an endoscopic device. A comprehensive value engineering study identified over 106 specific cost reduction opportunities. At the conclusion of the study, the customer was presented with a series of options and roadmaps to reduce costs by as much as 79%. These options spanned from design changes through to improvements to the supply-chain & manufacturing processes – all recommendations would maintain complete device functionality.